Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9365545

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9365520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9365504

    Salts of kukoamine B, preparation method and use thereof

    THE FIRST AFFILIATED HOSPITAL, THIRD MILITARY UNIVERSITY, PLA · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9364563

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9364540

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9364535

    Methods and compositions for modulating lymphangiogenesis, e.g., to treat transplant rejection, in a subject

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9364521

    Human tissue kallikrein 1 glycosylation isoforms

    DiaMedica Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9364505

    Therapeutic composition for treatment of glioblastoma

    Regents of the University of Minnesota · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9364501

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9364509

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9364471

    Compositions and methods of treating retinal disease

    Aldeyra Therapeutics, Inc. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9364448

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9364443

    Compositions and methods for drug delivery

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9364557

    Fold-back diabody diphtheria toxin immunotoxin and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9371337

    β-lactamase inhibitors

    The Regents of the University of California · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9371352

    Modified glycolipids and methods of making and using the same

    VACCINEX, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9371316

    Pyridine derivatives

    Asana BioSciences, LLC · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9370519

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9370527

    Amelioration of intestinal fibrosis and treatment of Crohn's disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9370487

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9372186

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9371368

    Compositions and methods for immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9371529

    RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

    Arrowhead Research Corporation · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9370510

    Small molecule compounds to treat hearing loss

    Fate Therapeutics, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9371516

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9371383

    Anti-ASIC1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9371375

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9371336

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9370581

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9370582

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9371277

    Benzamide compounds and related methods of use

    Northwestern University · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9371320

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9370559

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Heath Services · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9370505

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9370514

    Methods for fine particle manufacture

    The Board of Regents of the University of Texas System · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9370521

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9371287

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. CA 2968455

    COMPOSES ANTIBACTERIENS A LARGE SPECTRE D'ACTIVITE

    ACRAF [IT] · Granted Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. WO 2016096933

    MASITINIB COMBINÉ À UTILISER DANS LE TRAITEMENT DU CANCER DU SEIN

    AB SCIENCE [FR] · Granted Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 2016175302

    MASITINIB FOR TREATING GASTRIC CANCER

    AB SCIENCE [FR] · Granted Thu Jun 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9376690

    Templated nanoconjugates

    Northwestern University · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9376683

    Organic compositions to treat beta-ENaC-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9375424

    Compounds that treat malaria and prevent malaria transmission

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9376681

    miR-29 mimics and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9376481

    Methods of promoting CNS neuronal repair by inhibiting LRP-1

    The Regents of the University of California · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9376442

    Methylpyrrolopyrimidinecarboxamides

    TAKEDA GMBH · Granted Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.